| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 8309621 | Clinica Chimica Acta | 2018 | 18 Pages |
Abstract
Current evidence demonstrates that increased DcR3 expression correlates with a poor prognosis in cancer patients, which suggests that the expression status of DcR3 is a useful biomarker for the prediction of prognosis in patients with solid tumors.
Related Topics
Life Sciences
Biochemistry, Genetics and Molecular Biology
Biochemistry
Authors
Hua Ge, Chaojie Liang, Shulin Ren, Chaosen Yue, Jixiang Wu,